CDEK
← All organizations

MAP Pharmaceuticals

For profit
Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Dec 1, 2007

Last known activity

Apr 1, 2008

Acquired by Allergan → Smith, Kline & French → SmithKline Beckman → SmithKline Beecham → GlaxoSmithKline on Jan 1, 2013

Timeline

2000s

  1. Jan 1, 2000

    GlaxoSmithKline— Now

  2. Jan 1, 2003

    MAP Pharmaceuticals— Founded

2010s

  1. Jan 1, 2013

    Allergan— Acquired By

Drugs by trial phase (1 distinct, 2 trials)

Phase 3 (1 own, 0 via acquisition)

Indications

Studied for

Recent trials (2)

Details

Founded
Mountain View, CA, US Jan 1, 2003
Last known activity
Apr 1, 2008